EGF Theramed Health Corp. (CSE:TMED)

Market Cap	871.25K
Revenue (ttm)	n/a
Net Income (ttm)	-245.70K
Shares Out	11.62M
EPS (ttm)	-0.02
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	70,500
Average Volume	4,794
Open	0.0800
Previous Close	0.1000
Day's Range	0.0700 - 0.0800
52-Week Range	0.0400 - 0.3950
Beta	1.08
RSI	24.09
Earnings Date	Feb 21, 2025

About EGF Theramed Health

EGF Theramed Health Corp. engages in the development of psychedelic drugs for the treatment of mental health problems in Canada. The company offers psychedelics for the treatment of conditions, such as treatment-resistant depression, anxiety, PTSD, and depression, as well as natural health and wellness products. It also explores other medical areas, including weight loss, skin care, and heart disease. EGF Theramed Health Corp. is headquartered in Vancouver, Canada.

• Industry: Health Information Services
• Sector: Healthcare
• CEO: Connor Yuen
• Country: Canada
• Stock Exchange: Canadian Securities Exchange
• Ticker Symbol: TMED